“FDA Committee Greenlights Over-The-Counter Birth Control Pills: Empowering Women’s Health Choices!”
US Food and Drug Administration (FDA) advisory committees voted unanimously that the advantages of making Opill, a birth control pill, accessible for use without a prescription, would exceed the risks. Perrigo Co. announced the decision in a recent press release. The joint committee’s vote is non-binding; nevertheless, the FDA frequently follows advisory committee recommendations. Perrigo’s […]